Chitosan, a cationic polysaccharide, can enhance recombinant adenovirus vector (rAdv)-mediated gene transduction (AMGT) in cells that lack the rAdv receptor, coxsackie-adenovirus receptor (CAR). However, gene transduction using chitosan for such cell types has so far only been successful under non-physiological pH conditions as chitosan is insoluble under physiological pH conditions. Here we report that NaHCO 3 can greatly improve the solubility of chitosan at physiological pH (pH 7.4). We show that this chitosan/NaHCO 3 solution increases AMGT approximately 8-24-fold in several CAR-absent or CAR low-level-expressing cell lines from different species and tissue origins (for example, Chinese hamster ovary, B16, DC2.4 and RD cells). Chitosan/ NaHCO 3 also increases AMGT of CAR-positive cell lines 1.6-1.7-fold. The presence of fetal bovine serum during rAdv treatment and impurities in rAdv preparations did not adversely affect transduction efficiency. Moreover, chitosan/NaHCO 3 promotes AMGT efficiency for murine melanoma B16 xenografted tumor cells in C57/BL6 mice. Our new protocol provides a CAR-independent, highly efficient and convenient technique to enhance AMGT both in vitro and in vivo under physiological pH conditions.
INTRODUCTION
Recombinant adenovirus serotype 5 vectors (rAdvs) have been broadly used for gene therapy studies owing to their high efficiency of gene transduction and expression in in vitro and in vivo model systems. 1, 2 Gene transduction mediated by rAdv mainly relies on the expression of coxsackie-adenovirus receptor (CAR). 3 As some cells express CAR at low to no levels, some important gene therapy target cells, such as hematopoietic cells, endothelial cells, skeletal and smooth muscle cells, and certain cancer cells are refractive to rAdv infection. [4] [5] [6] [7] [8] [9] [10] Therefore, improvement of rAdv-mediated transduction (AMGT) to cells that do not contain CAR or express it only at low-levels can advance the practice of rAdv-based gene therapy.
Cationic compounds can enhance rAdv association owing to a net negative charge on cell surface membranes. This charge-affinity interaction facilitates the entry of rAdv into cells through a receptor-ligand-independent interaction (a CAR-independent mechanism). Several reports have shown that cationic liposomes or cationic polymers can markedly improve the transduction efficiency of rAdv in cells that do not contain CAR or express it only at low levels. [11] [12] [13] However, the use of these molecules is restricted because of the wellknown cytotoxicity often associated with cationic compounds. 14, 15 Chitosan, a cationic polymer of polysaccharide consisting of D-glucosamine and N-acetyl-D-glucosamine, has been shown to improve gene transduction in AMGT, 16, 17 as well as transfection of naked DNA. 18, 19 Chitosan is less toxic and immunogenic than other cationic polymers. 20, 21 However, chitosan's ability to promote gene transduction has been hampered by its poor solubility under physiological pH conditions. Kawamata and colleagues 17 recently reported that although chitosan could efficiently improve AMGT in an acidic medium (pH 6.4), this effect was abolished under physiological pH conditions (pH 7.4). Similar results were also observed in the case of DNA transfection. 18, 19 To overcome use of acidic media, which is not well tolerated by most cell lines, it is critical to improve the solubility of chitosan under physiological pH conditions to facilitate gene transduction.
Several strategies have been employed to improve the solubility of chitosan under physiological conditions. Most attempts have focused on preparing water-soluble derivatives of chitosan, 22 such as trimethylated chitosan [23] [24] [25] or pegylated chitosans. 26, 27 However, such complex modification of chitosan can interfere with its chemical and biological properties [27] [28] [29] and the procedures of preparing chitosan derivatives, for example, self-branched glycosylated chitosan oligomers, are complex and not easily adapted for most laboratories. 30 An alternative to these approaches is to develop a new preparation procedure, which can dissolve chitosan under physiological pH conditions. This strategy can circumvent the complicated chemical modification and synthesis, as well as avoid the interference to its biological activities.
In the present study, we have tested various compounds in their ability to improve chitosan's solubility. We found that NaHCO 3 can greatly improve the solubility of chitosan at physiological pH (pH 7.4). We show here that a chitosan/NaHCO 3 solution can efficiently increase AMGT in several CAR-absent and CAR lowlevel-expressing cell lines, as well as in CAR-positive cell lines. Chitosan/NaHCO 3 also promotes AMGT efficiency for murine melanoma B16 xenografted tumor cells in C57/BL6 mice.
RESULTS

Preparation and characterization of chitosan/NaHCO 3
To improve the solubility of chitosan, we tested various compounds in their ability to solubilize chitosan under physiological pH conditions (pH 7.4). These compounds included glycerol, glucose, mycose, alginic acid and folic acid, as well as various other organic and inorganic salts (data not shown). We observed that only NaHCO 3 solution greatly improved the solubility of chitosan. The chitosan sodium bicarbonate solution (chitosan/NaHCO 3 ) formed a homogeneous solution at pH 7.4. Precipitates were observed in chitosan acetate solution (chitosan/acetate) at pH 7.4 ( Figure 1a) .
We generated chitosan/NaHCO 3 in a two-step process: (1) chitosan was first dissolved in acidic solutions, such as acetic acid or HCl; (2) NaHCO 3 was used to rapidly neutralize the acidic solution. We found that it was critical that the pH of the acidic solution used to dissolve chitosan is p5, and that the neutralizing solution be added as quickly as possible. Thus, NaHCO 3 solution was added in bulk (not gradually) under vigorous vortex. The resulting solution of chitosan/NaHCO 3 was stable at 4 1C. No precipitation could be detected after 3 months storage at 4 1C when it was centrifuged at 13 000 r.p.m. for 5 min.
To examine the chemical property of chitosan in chitosan/NaHCO 3 , chitosan was extracted from the NaHCO 3 solution by ethanol precipitation. This precipitant could easily be re-dissolved with either water or 0.1 M NaHCO 3 . However, the chitosan that was re-dissolved in water completely precipitated again within 5 minutes, while the chitosan re-dissolved in 0.1 M NaHCO 3 remained stable in solution. These observations suggest that NaHCO 3 in the solution is crucial for the stability of chitosan.
To investigate the dispersed state of chitosan in NaHCO 3 solution (pH 7.4), the zeta potential and particle size of chitosan/NaCHO 3 were measured by dynamic light scatter. We observed that chitosan in NaHCO 3 carried a positive charge (2.9 ± 1.4), which was weaker than that of chitosan in chitosan/acetate (pH 6.4; 14.4 ± 2.8) (Figure 1b) . The hydrodynamic diameter of particles in chitosan/NaHCO 3 (590 nm) was similar to that of particles in chitosan/acetate (pH 6.4; 650 nm) (Figure 1c ).
Cytotoxicity of chitosan/NaHCO 3
To examine the cytotoxicity of chitosan/NaHCO 3 , we used a dehydrogenase-based assay in order to measure Chinese hamster ovary (CHO) cell viability after treatment with increasing concentrations of chitosan solutions at pH 7.4. Cells treated with chitosan/NaHCO 3 did not exhibit detectable cytotoxicity in the range of chitosan concentrations tested (3.125-200 mg ml À1 ). In contrast, polyethylenimine, a well-characterized cationic polymer, induced cytotoxicity at X6.25 mg ml À1 (Figure 2 ). These results suggest that chitosan, when Effect of chitosan/NaHCO 3 on AMGT to CHO cells To determine the effect of chitosan/NaHCO 3 on AMGT at physiological pH, we performed gene transduction assays on CHO cells, which have been shown to be CAR-negative. 3 We assessed the transduction efficiency of Ad5-LacZ by measuring the b-galactosidase expression level 24 h post infection. The transduction efficiency of Ad5-LacZ alone on CHO cells was extremely low (Figure 3a) , consistent with the fact that CHO cells do not express CAR. In contrast, when mixed with 3.125-100 mg ml À1 chitosan/NaHCO 3 , the transduction efficiency of Ad5-LacZ was significantly elevated (up to 13-fold, at 25 mg ml À1 chitosan concentration) compared with cells treated by chitosan/ acetate or Ad5-LacZ alone under physiological conditions (for details of statistical analysis, see Figure 3a ). Chitosan/acetate had little effect on AMGT under physiological pH conditions consistent with the results reported by Kawamata et al. 17 Thus, our data indicate that chitosan/NaHCO 3 can greatly improve the efficiency of AMGT under physiological pH conditions.
To investigate whether chitosan/NaCHO 3 could enhance AMGT at different rAdv doses, we examined the b-galactosidase activity in CHO cells after treatment with different multiplicities of infection (MOIs) of rAdv (MOI¼2, 10, 20, or 30) at different chitosan concentrations (3.125-100 mg ml À1 ) (Figure 3b ). Our data indicate that chitosan/ NaHCO 3 could promote transduction in each of the rAdv MOIs tested and that a concentration of 12.5-25 mg ml À1 chitosan/NaHCO 3 appears to be optimal for transduction in all tested rAdv MOIs. As the expression of b-galactosidase could be elevated at higher rAdv MOIs, we used 20 MOI rAdv and 12.5 mg ml À1 chitosan in subsequent in vitro experiments in this study.
When we examined the effect of incubation time on transduction, we observed increasing transduction efficiency with increasing time. This was most evident between 2 and 8 h of incubation of cells with chitosan/NaCHO 3 . Optimal transduction occurred at 8 h ( Figure 3c ). An increase in AMGT was observed even after 24-h treatment without adverse effects. These observations suggest that the rAdvchitosan-NaCHO 3 mixture is well tolerated by the cells.
Effects of the molecular weight of chitosan, serum and rAdv impurities on AMGT We investigated the effects of several factors-the molecular weight of chitosan, the serum in the cell culture and the impurities in the rAdv solution-on chitosan/NaHCO 3 -mediated AMGT.
We compared the effects of chitosans that had different molecular weights (high, medium and low) in the NaHCO 3 solution on AMGT. These various chitosans significantly increased the b-galactosidase activity in CHO cells compared with control Ad5-LacZ alone (Figure 4a ). We found that high-molecular-weight chitosan was more efficient at lower concentrations (3.125-12.5 mg ml À1 ), whereas Chitosan/NaHCO 3 improved gene transduction H Zhong et al low-molecular weight-chitosan had higher transduction efficiency at higher concentrations (12.5-50 mg ml À1 ). As serum is widely used for cell culture and usually can attenuate the efficiency of DNA transduction, we investigated the compatibility of chitosan/NaHCO 3 with fetal bovine serum. We observed that chitosan/NaHCO 3 enhanced AMGT in the presence or absence of this serum (Figure 4b) . Furthermore, the b-galactosidase activity in cells treated with 2% serum supplement was significantly higher than that in cells without serum (t test, P¼0.001). Our results indicate that serum does not affect the efficacy of chitosan/NaHCO 3 on AMGT.
As purification of rAdv is a time-consuming and expensive procedure, we set out to determine whether chitosan/NaHCO 3 could enhance AMGT without using purified rAdv. We found that chitosan in a concentration as low as 12.5 mg ml À1 significantly improved unpurified Ad5-LacZ-mediated gene transduction (t test, P¼0.005). Although the augmentation effect of chitosan/NaHCO 3 on the unpurified Ad5-LacZ was lower than that of the purified virus, there was no observed statistical difference (t test, P¼0.349) (Figure 4c ). These data suggest that chitosan can promote AMGT even in the presence of impurities in the rAdv preparation.
Effect of chitosan/NaHCO 3 on AMGT in multiple cell lines with different CAR expression level Having characterized the ability of chitosan/NaHCO 3 to enhance AMGT in CHO cells, we extended our study to other cell lines with different CAR expression levels. We first tested its efficiency on three cell lines of different species and tissue origin: B16 (mice; epithelium cell origin), DC2.4 (mice; hematopoietic cell origin) and RD (human; muscle cell origin). These cell lines do not express CAR. [31] [32] [33] We found that both b-galactosidase activity assay (Figure 5a ) and X-gal staining (Figure 5b ) indicated that chitosan/NaHCO 3 treatment enhanced AMGT compared with Ad5-LacZ alone in these cell lines. The efficacy was highest in the DC2.4 cells (24-fold) and lowest in the RD cells (8-fold; Figure 5a ). The optimal concentration of chitosan was 12.5, 25, 6.25 and 12.5 mg ml À1 in CHO, DC2.4, RD and B16 cells, respectively (Figure 5a ).
We then investigated whether chitosan/NaHCO 3 could improve the efficiency of rAdv transduction on cell lines expressing CAR, such as for A549 and HEp-2, which express high-level CARs on their surface. Our results showed that chitosan could also slightly enhance the transduction of Ad5-LacZ on A549 and HEp-2 by 1.6-1.7-fold compared with Ad5-LacZ alone (Figure 5c ).
Taken together, our findings indicate that chitosan/NaHCO 3 can enhance AMGT in cell lines that express low-or high-level CAR.
Effects of chitosan/NaHCO 3 on AMGT in vivo To determine whether chitosan-enhanced AMGT observed in vitro is also valid in vivo, we performed an in vivo AMGT experiment. For this purpose, a mixture of Ad5-Luc with chitosan/NaHCO 3 (final concentration 12.5 mg ml À1 ) was used to transduce the firefly luciferase gene expression in murine melanoma B16 xenografted tumor cells in C57/BL6 mice. Ad5-Luc functioned as a control. The expression of luciferase in the B16 tumor was monitored with a non-invasive optical imaging system at days 1, 2, 3, 6 and 10 post infection. 34, 35 Bioluminescence imaging showed that the intensity of light emitted by intratumour luciferase increased in the Ad5-Luc/chitosan group compared with the Ad5-Luc alone group (Figure 6a) . The image analysis data showed that total photon flux values from tumor areas in the Ad5-Luc/chitosan group were significantly higher than those of Ad5-Luc alone for the first three days post infection (t test two-tailed), day 1: P¼0.039; day 2: P¼0.046; day 3: P¼0.015) (Figure 6b) . Notably, Figure 4 Effect of molecular weight of chitosan, serum and rAdv impurities on AMGT enhanced by chitosan/NaHCO 3 . (a) Effects of molecular weights on chitosan-mediated augmentation of Ad5-LacZ transduction. Ad5-LacZ (MOI¼20) mixed with chitosans of different molecular weights at indicated concentrations were used to infect CHO cells. (b) Effect of serum on chitosan/NaHCO 3 -mediated AMGT. CHO cells were infected by Ad5-LacZ (MOI¼20) with chitosan/NaHCO 3 (12.5 mg ml À1 ) in the presence or absence of fetal bovine serum. The rAdv/chitosan solutions were replaced with maintaining medium 4 hours post infection. *t test (two-tailed) and P values for groups compared are shown above the bars. (c) Influence of impurities in rAdv preparations on Ad5-LacZ transduction efficiency. Unpurified or purified Adv-LacZ (MOI¼20) was mixed with chitosan/NaHCO 3 (12.5 mg ml À1 ) prior to their infection to CHO cells. In all experiments, b-galactosidase activity was analyzed at 24 h post infection. Data are presented as mean±s.d. for three independent experiments. The statistical significance between groups is examined by two-tailed t test. P values for groups compared are shown above the bars.
Chitosan/NaHCO 3 improved gene transduction H Zhong et al the total photon flux of Ad5-Luc/chitosan group was 17.9-fold greater than that of the Ad5-Luc alone group at the first day of treatment. These results indicate that chitosan/NaHCO 3 can promote AMGT in vivo.
DISCUSSION
In this study, we successfully dissolved chitosan under physiological pH (pH 7.4) conditions using NaHCO 3 . We demonstrate that this new chitosan solution can markedly increase adenovirus 5 vectormediated gene transduction both in vitro and in vivo. Compared with previously reported protocols, 22-27 the preparation protocol reported here has the following advantages: (1) The chitosan/NaHCO 3 solution does not induce cytotoxicity even at concentrations (200 mg ml À1 ) well beyond its highest transduction efficiency (12.5-25 mg ml À1 ). (2) At physiological pH, chitosan/NaHCO 3 induces a 13-fold increase in gene transduction in vitro. This efficiency was substantially higher than that of chitosan/acetate under pH6.4 (9-fold increase). 17 Chitosan/NaHCO 3 promoted high gene transduction efficiencies on both Ad5-resistant and Ad5-susceptible cell lines derived from different tissues and species. Chitosan-mediated transduction is CARindependent, which may have broad applications in AMGT. (3) Our preparation protocol is much simpler, cheaper and more convenient than the chemical synthesis of the chitosan derivatives; as such, it will allow broad applications in various laboratories. (4) More importantly, this advance may have broad applicability in in vivo gene delivery owing to its non-toxic and high-efficient properties. Highdosage rAdv has been applied in gene therapies involving CARdeficient cells owing to the low efficiency of AMGT. 36, 37 However, high dosage rAdv leads to liver toxicity and thus raises safety concerns. 38 Our study shows that chitosan/NaHCO 3 can greatly improve the efficiency of AMGT, which may allow us to lower the rAdv dosage in gene therapy. More importantly, chitosan/NaHCO 3 can enhance AMGT for dendritic cells (24-fold in DC2.4 in vitro), indicating that it may be applicable for ex vivo procedures of dendritic cell-based cancer gene therapy. 39 The mechanism underlying NaHCO 3 's ability to promote the solubility of chitosan at physiological pH is unclear. It is possible that HCO 3 À has special affinity to the amine groups in chitosan. This specific interaction may alter and weaken the hydrogen bond network of chitosan under physiological conditions and may help chitosan to remain stable under such conditions. 40 Because HCO 3 À is not covalently bound to chitosan, the presence of HCO 3 À in the solution is crucial to keep the solubility of chitosan.
We found that higher doses of chitosan (100-200 mg ml À1 ) lead to reduced transduction efficiency (Figure 3a) . The molecular Chitosan/NaHCO 3 improved gene transduction H Zhong et al mechanism responsible for this reduction is obscure. It is possible that chitosan has high viscocity at high concentrations, which may lead to the decrease of adenovirus-chitosan complex formation. 41 It is also possible that at high concentrations, chitosan will compete with the adenovirus-chitosan complexes for interaction with cell surfaces, which in turn may interfere with the transduction of adenoviruses. Further investigations are needed to address the precise mechanisms behind this phenomenon. Our study showed that chitosan/NaHCO 3 could greatly improve AMGT at various rAdv MOI conditions in b-galactosidase activity assays. However, compared with higher MOI doses, the expression level of b-galactosidase was reduced at lower doses (apparently MOI¼2), under both rAdv alone and chitosan treatment conditions. Similar observations have also been made by other groups. 42, 43 In addition, some reports have shown that the expression level of target genes is not always linearly correlated with the rAdv MOI. 44, 45 The mechanisms responsible for such disparities are unclear. It is possible that when the concentration of rAdv is high enough, interactions between rAdv and cell membranes can take place in the presence of chitosan/NaCHO 3 . However, the exact mechanism needs to be further elucidated.
Charge affinity has been regarded as the mechanism responsible for most cationic polymer-mediated gene transductions. However, we found that chitosan/NaHCO 3 shows a much lower zeta potential (+3 mV) than most cationic polymers (+10 to +30 mV) and chitosan/ acetate. This characteristic is a remarkable contrast to its high efficiency. Similarly, PEG-polyethylenimine derivatives show high DNA transduction ability, but with lower zeta potential (+3 mV). 46, 47 Thus, charge affinity may not be the only mechanism by which chitosan enhances AMGT. Additional mechanisms, which have not been identified yet, may be involved in this process.
Our study also shows that the effect of chitosan/NaHCO 3 on AMGT is not adversely affected by serum or impurities in rAdv preparations in vitro. Experiments with mice demonstrate that the enhancing effect of chitosan/NaCHO 3 on AMGT in vivo (17.9-fold) is similar to that found in in vitro experiments (15-fold) . Although additional studies are needed to further validate and extend the application of this protocol for AMGT, based on our findings it is conceivable that our approach may have application in gene therapy practices.
In summary, we have successfully developed a chitosan water solution using NaHCO 3 under physiological pH (pH 7.4), providing a CAR-independent, high-efficient, non-cytotoxic and convenient approach to enhance adenovirus type 5 vector-mediated gene transduction both in vitro and in vivo.
MATERIALS AND METHODS
Preparation of chitosan solutions
High-molecular-weight chitosan (HMWC; 475% deacetylated, 800-2000 cP, 1% (w/v) in 1% acetic acid), medium-molecular-weight chitosan (MMWC; 75-85% deacetylated, 200-800 cP, 1% (w/v) in 1% acetic acid) and low-molecular-weight (LMWC; 75-85% deacetylated, 20-200 cP, 1% (w/v) in 1% acetic acid) were all obtained from Sigma Aldrich (St Louis, MO, USA). Two different chitosan solutions were prepared: (1) 0.2% chitosan sodium bicarbonate solution (chitosan/NaHCO 3 ; pH 7.4): 0.03 g chitosan (HMWC was used in the present study unless noted) was dissolved in 11.3 ml water with addition of 100 ml ice acetate acid. Then, 3.6 ml of 1 M NaHCO 3 was added in bulk during vortexing. NaHCO 3 (1 M) was then used to adjust the solution to pH 7.40. (2) 0.2% chitosan acetate solution (chitosan/acetate; pH 6.4), prepared as described elsewhere. 17 Briefly, chitosan was dissolved in acetate acid solution to reach a final concentration of 0.2% (w/v) and was adjusted to pH 6.40 with 1 M NaOH.
Cell culture
CHO cells were grown in Dulbecco's modied Eagle's medium/F12 medium (Hyclone, Logan, UT, USA). B16 (murine melanoma cell line), HEp-2 (human epidermoid carcinoma of the larynx), A549 (human lung cancer cell line), RD (human rhabdomyosarcoma cell line) and 293 (human embryionic kidney cell) cells were cultured in Dulbecco's modied Eagle's medium (Hyclone) medium. DC2.4 (murine dendritic) cells were maintained in RPMI 1640 medium (Hyclone). All cell culture media were supplemented with 10% fetal bovine serum (Hyclone), 100 IU ml À1 penicillin and 100 mg ml À1 streptomycin (Hyclone).
Recombinant adenoviruses
rAdvs expressing Escherichia coli b-galactosidase (Ad5-LacZ) or firefly luciferase (Ad5-Luc), for which E1/E3 had been deleted, were purchased from Beijing FivePlus Molecular Medicine Institute (Beijing, China). rAdvs were propagated in 293 cells and purified through two rounds of CsCl density gradient centrifugation as previously described. 48 
Figure 6
Effect of chitosan/NaHCO 3 on rAdv transduction to B16 cell xenografted tumor in mice. (a) Representative bioluminescence images of C57/BL6 mice with B16 xenografted tumor at days 1, 2 and 3 after intratumoral injection of a mixture of Ad5-Luc and chitosan/NaHCO 3. Ad5-Luc alone was used as a control. (b) Photon flux in the tumor area post intratumoral injection of the mixture of Ad5-Luc and chitosan/NaHCO 3 . The data were monitored at indicated days. Ad5-Luc alone was used as a control. The statistical significance between Ad5-Luc/chitosan and Ad5-Luc alone groups was examined by twotailed t test. P values for groups compared are shown above the bars.
Chitosan/NaHCO 3 improved gene transduction H Zhong et al Zeta potential and size analysis Zeta potential and particle size of chitosan/NaHCO 3 or chitosan/acetate solutions were determined in triplicate by dynamic light scatter on a ZetaPALS apparatus, following the manufacturer's instructions (Brookhaven Instruments Corporation, Holtsville, NY, USA).
Cytotoxicity assay
CHO cells were plated at 4Â10 4 cells per well in 96-well plates in 100 ml media and incubated overnight at 37 1C. Chitosan/NaHCO 3 (pH 7.4), chitosan/ acetate (pH 6.4) or 0.2% polyethylenimine water solution (positive control) was diluted to 50% using a cascade in PBS (pH 7.4). Then, the maintaining medium (Dulbecco's modied Eagle's medium/F12 containing 2% fetal bovine serum unless otherwise noted; pH 7.4) was added. A volume of 150 ml of the mixture was placed into the wells of 96-well plates, which were seeded with CHO cells in duplicate after the removal of cell culture medium. The maintaining medium was used as a control. The final concentration of chitosan or polyethylenimine in the cell culture media was between 3.125 and 200 mg ml À1 . After 24-h incubation, the surviving cells were measured using the Cell Count Kit-8 (Dojindo Corporation, Japan) according to the manufacturer's instructions.
In vitro transduction of adenovirus-chitosan complex CHO, B16, DC2.4, RD, A549 or HEp-2 cells were plated in 96-well plates at 4Â10 4 cells per well and incubated overnight at 37 1C. To formulate the rAdvchitosan complex, different concentrations of Ad5-LacZ and chitosan were added to 150 ml PBS, vortexed for 5 s and incubated for 20 min at room temperature, then mixed with 450 ml maintaining medium. The Ad5-LacZchitosan complex was inoculated into cell cultures at 150 ml per well in triplicate after removal of the culture media. The transduction efficiency was examined by b-galactosidase activity assay or X-gal staining 24 h after the initiation of adenovirus/chitosan treatment.
b-Galactosidase activity measurement
After being washed with PBS, cells were lysed with 50 ml per well reporter lysis buffer (Promega, Madison, WI, USA) for 30 min at room temperature followed by a subsequent À20 1C/37 1C freeze-thawing cycle. Using the b-galactosidase Enzyme Assay System (Promega), 20 ml of samples from each well were used to measure b-galactosidase activity according to the manufacturer's instructions.
X-gal staining
After fixation by 4% paraformaldehyde solution for 10 min at room temperature, cells were washed with PBS and stained with 50 ml per well X-gal staining solution for 3 h followed by two PBS washes. Images of stained cells were taken under a Nikon Eclipse TS100 with DS-2Mv-U2 system (Nikon Corp., Tokyo, Japan).
Animal experiments
C57/BL6 mice (4-6 weeks old) were provided by the Institute of Laboratory Animal Sciences, Chinese Academy of Medical Sciences (ILAS, CAMS; Beijing, China). B16 cells were harvested at exponential growth phase, washed twice and resuspended with Hank's balance salt solution to a final density of 5Â10 7 per ml. To develop a melanoma model in mice, 5Â10 6 B16 cells in 100 ml were injected subcutaneously at the center site of the back area of each C57/BL6 mouse. 49 Two groups of mice (five mice each group) were used. The mice were used for intratumor viral administration when tumor diameter reached 0.5 cm (9 days after incubation). After being anesthetized, mice were treated with Ad5-Luc (5Â10 10 virus particles in 100 ml volume) complexed with chitosan/ NaHCO 3 (12.5 mg ml À1 ), or Ad5-Luc alone as a control. At 1, 2, 3, 6 or 10 days post treatment, mice were anesthetized and injected intraperitoneally with D-luciferin (Promega) at a dose of 25 mg per kg mouse body weight 10 min before the images of photons emitted from the firefly luciferase reaction were acquired by the ICE Chemi & Fluo System (Photometrics, Tucson, AZ, USA). Exposure time was 10 min. The total photon flux from the tumor region was determined by SlideBook software (Intelligent Imaging Innovations, Inc., Denver, CO, USA).
